Home pageGEDSF • OTCMKTS
add
Gedeon Richter
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
(HUF) | set 2024info | Variazione Y/Y |
---|---|---|
Entrate | 216,73Â Mld | 14,95% |
Spese di gestione | 94,69Â Mld | 10,59% |
Utile netto | 37,06Â Mld | -32,07% |
Margine di profitto netto | 17,10 | -40,89% |
Utili per azione | — | — |
EBITDA | 76,39Â Mld | 23,89% |
Aliquota fiscale effettiva | 19,13% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(HUF) | set 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 74,99Â Mld | -29,24% |
Totale attivo | 1,49Â Bln | 9,53% |
Totale passivo | 258,83Â Mld | -1,37% |
Patrimonio netto totale | 1,23 Bln | — |
Azioni in circolazione | 182,62 Mln | — |
Prezzo/valore contabile | 0,00 | — |
Redditività dell'attivo | 10,29% | — |
Rendimento sul capitale | 11,59% | — |
Flusso di cassa
Flusso di cassa netto
(HUF) | set 2024info | Variazione Y/Y |
---|---|---|
Utile netto | 37,06Â Mld | -32,07% |
Liquidità di esercizio | 67,55 Mld | 56,30% |
Contanti da investimenti | -13,69Â Mld | 54,12% |
Contanti da finanziamenti | -36,70Â Mld | -409,23% |
Flusso di cassa netto | 17,12Â Mld | -34,71% |
Flusso di cassa libero | 13,19Â Mld | 1.594,12% |
Informazioni
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
Fondazione
1901
Sito web
Dipendenti
11.603